Plasma chloroquine concentrations in young and older malaria patients treated with chloroquine

Acta Tropica

Volumn 66, Issue 3, 1997, Pages 155-161

  Maitland, Kathryn ^a   Williams, Thomas N ^a   Kotecka, Barbara M ^b   Edstein, Michael D ^b   Rieckmann, Karl H ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Bioassay; Chloroquine; Drug resistance; Malaria

Indexed keywords

CHLOROQUINE;

ADOLESCENT; ADULT; ARTICLE; BIOASSAY; CHILD; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALARIA; ORAL DRUG ADMINISTRATION; VANUATU;

ADOLESCENT; ADULT; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG RESISTANCE; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED;

EID: 0030818857     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(97)00046-6     Document Type: Article

References (7)

1. Alvan G., Ekman L., Lindstrom B. Determination of chloroquine and its desethyl metabolite in plasma, red blood cells and urine by liquid chromatography. J. Chromatogr. 229:1982;241-247.
2. Kotecka B., Rieckmann K.H. Chloroquine bioassay using malaria microcultures. Am. J. Trop. Med. Hyg. 49:1993;460-464.
3. Rieckmann K.H., Sax L.S., Campbell G.H., Mrema J.E. Drug sensitivity of Plasmodium falciparum - An in vitro microtechnique. Lancet. i:1978;22-23.
4. White N.J., Miller K.D., Churchill F.C., Berry C., Brown J., Williams S.B., Greenwood B.M. Chloroquine treatment of severe malaria in children. Pharmacokinetics, toxicity, and new dosage recommendations. N. Engl. J. Med. 319:1988;1493-1500.
5. White N.J. Drug treatment and prevention of malaria. Eur. J. Clin. Pharmacol. 34:1988;1-14.
6. World Health Organization (1973) Chemotherapy of malaria and resistance to antimalarials. Report of a WHO Scientific Working Group. Geneva, WHO. Tech. Rep. Ser. 529: pp. 30.
7. World Health Organization (1990) In vitro micro-test (Mark II) for the assessment of the response of Plasmodium falciparum to chloroquine, mefloquine, quinine, sulfadoxine/pyrimethamine and amodiaquine. Geneva, WHO mimeographed document, no. MAP/87.2.